Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma
Launched by CENTRE HOSPITALIER DEPARTEMENTAL VENDEE · Mar 11, 2022
Trial Information
Current as of November 11, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating a new method of pain management for patients with severe chest injuries, specifically those who have broken more than two ribs on one side. The study aims to see if using a technique called erector spinae plane catheter placement, combined with standard pain relief medication, can help reduce pain and prevent breathing problems better than the usual epidural method, which can be complicated and has some risks.
To participate in this study, patients need to be at least 18 years old, have a specific kind of chest trauma, and be able to communicate their pain levels. They should also be admitted to intensive care but not require a breathing machine. If eligible, participants can expect to receive the new pain management technique and be monitored closely for its effects. The goal is to improve recovery and minimize complications related to breathing after a chest injury.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Age ≥ 18 years
- • Unibilateral chest trauma with fracture \> 2 ribs on one side
- • Admission to Intensive Care Medicine
- • Non-intubated patient, able to respond to a pain scale score and perform a vital capacity
- • Numerical Scale \> 3 on forced inspiration despite use of systemic analgesics
- • CV ≤ 80% theoretical at inclusion
- • Time \< 24 hours from admission to the service to inclusion
- • Time \< 48h between trauma and inclusion
- • Patient affiliated to the social security system or entitled to it
- • Patient able to understand the protocol, having agreed to participate in the study and having given express oral consent
- Exclusion Criteria:
- • Intubated, ventilated patient
- • Indication for laparotomy or thoracotomy
- • Spinal cord injury
- • Severe head injury
- • Bilateral thoracic trauma
- • Patient included in a category 1 clinical interventional study involving analgesic treatment
- • Patients under legal protection or deprived of liberty
- • Pregnant or breastfeeding women, or women with childbearing potential without effective contraception
- • Refusal to participate
- • Unable to understand the protocol and its requirements and/or unable to give express oral consent
About Centre Hospitalier Departemental Vendee
The Centre Hospitalier Départemental Vendée is a prominent healthcare institution dedicated to advancing medical knowledge through rigorous clinical research. With a commitment to patient-centered care and innovative treatment approaches, the center actively sponsors clinical trials across various therapeutic areas. By collaborating with multidisciplinary teams of healthcare professionals, the institution aims to enhance clinical outcomes and contribute to the overall improvement of public health. Its strategic focus on ethical research and adherence to regulatory standards ensures that all studies are conducted with the highest level of integrity and scientific rigor.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
La Roche Sur Yon, France
Patients applied
Trial Officials
Laureen GUILLEMIN
Principal Investigator
Centre Hospitalier Départemental Vendée
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials